ResMed enters accelerated share repurchase agreement for $450 million stock
ResMed (NYSE:RMD) entered an accelerated share repurchase agreement to repurchase $450 million of common stock, per an SEC filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.